Literature DB >> 18514969

Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.

Igor I Slowing1, Juan L Vivero-Escoto, Chia-Wen Wu, Victor S-Y Lin.   

Abstract

In this review, we highlight the recent research developments of a series of surface-functionalized mesoporous silica nanoparticle (MSN) materials as efficient drug delivery carriers. The synthesis of this type of MSN materials is described along with the current methods for controlling the structural properties and chemical functionalization for biotechnological and biomedical applications. We summarized the advantages of using MSN for several drug delivery applications. The recent investigations of the biocompatibility of MSN in vitro are discussed. We also describe the exciting progress on using MSN to penetrate various cell membranes in animal and plant cells. The novel concept of gatekeeping is introduced and applied to the design of a variety of stimuli-responsive nanodevices. We envision that these MSN-based systems have a great potential for a variety of drug delivery applications, such as the site-specific delivery and intracellular controlled release of drugs, genes, and other therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514969     DOI: 10.1016/j.addr.2008.03.012

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  322 in total

Review 1.  Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.

Authors:  Rolando E Yanes; Fuyuhiko Tamanoi
Journal:  Ther Deliv       Date:  2012-03

2.  FITC labeled silica nanoparticles as efficient cell tags: uptake and photostability study in endothelial cells.

Authors:  Srivani Veeranarayanan; Aby Cheruvathoor Poulose; Sheikh Mohamed; Athulya Aravind; Yutaka Nagaoka; Yasuhiko Yoshida; Toru Maekawa; D Sakthi Kumar
Journal:  J Fluoresc       Date:  2011-09-29       Impact factor: 2.217

3.  Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line.

Authors:  Huan Meng; Monty Liong; Tian Xia; Zongxi Li; Zhaoxia Ji; Jeffrey I Zink; Andre E Nel
Journal:  ACS Nano       Date:  2010-08-24       Impact factor: 15.881

4.  Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide.

Authors:  Amitava Das; Priyabrata Mukherjee; Sumit K Singla; Praveen Guturu; Megan C Frost; Debabrata Mukhopadhyay; Vijay H Shah; Chitta Ranjan Patra
Journal:  Nanotechnology       Date:  2010-07-08       Impact factor: 3.874

Review 5.  Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin.

Authors:  Haiqi Chen; Dolores D Mruk; Weiliang Xia; Michele Bonanomi; Bruno Silvestrini; Chuen-Yan Cheng
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

6.  Autophagy upregulation promotes macrophages to escape mesoporous silica nanoparticle (MSN)-induced NF-κB-dependent inflammation.

Authors:  Chen Xi; Jie Zhou; Shuzhang Du; Shaojun Peng
Journal:  Inflamm Res       Date:  2016-02-09       Impact factor: 4.575

7.  Nonporous Silica Nanoparticles for Nanomedicine Application.

Authors:  Li Tang; Jianjun Cheng
Journal:  Nano Today       Date:  2013-06       Impact factor: 20.722

8.  Improving STING Agonist Delivery for Cancer Immunotherapy Using Biodegradable Mesoporous Silica Nanoparticles.

Authors:  Kyung Soo Park; Cheng Xu; Xiaoqi Sun; Cameron Louttit; James J Moon
Journal:  Adv Ther (Weinh)       Date:  2020-07-21

Review 9.  Hybrid nanoparticles for combination therapy of cancer.

Authors:  Chunbai He; Jianqin Lu; Wenbin Lin
Journal:  J Control Release       Date:  2015-09-24       Impact factor: 9.776

Review 10.  DNA nanomaterials for preclinical imaging and drug delivery.

Authors:  Dawei Jiang; Christopher G England; Weibo Cai
Journal:  J Control Release       Date:  2016-08-13       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.